Nur Ink Innovations EBITDA CAGR 5Y
EBITDA CAGR (5 Year) of Nur Ink Innovations (NURI.TA) as of Oct 29, 2026.
Get this data via API
Financial Data API
EBITDA CAGR 5Y
-
Last updated:
EBITDA CAGR (5 Year) of Nur Ink Innovations is 2026 - . EBITDA CAGR (5 Year) of Nur Ink Innovations was 2025 - . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Nur Ink Innovations Stock analysis
What does Nur Ink Innovations do? Nur Ink Innovations Ltd develops water-based pigment inks for digital printers, specializing in research, development, and production. Their core product, Digital Sol-Gel, uses advanced 3D cross linking chemistry to create pigment inks tailored for Direct-to-Garment (DTG), Direct-to-Textile (DTT), and roll-to-roll printing applications including indoor and outdoor advertising and wallpapers. The company also produces a white water-based pigment dispersion and additional functional inks for diverse markets and technologies, customizing solutions to specific printer requirements.
Customers include manufacturers of digital printers and printing service providers who require specialized inks for DTG, DTT, and roll-to-roll printing. The company's inks are designed to meet the technical specifications of various printers, ensuring compatibility and performance across different applications. Nur Ink Innovations Ltd focuses on functional inks that enhance print quality and durability for both indoor and outdoor use.
The business model revolves around selling proprietary ink formulations directly to printer manufacturers and printing service providers. By developing customized inks for specific printer models, the company establishes long-term partnerships with clients seeking high-performance solutions. The white water-based pigment dispersion and additional functional inks further diversify the product portfolio, targeting niche markets within the digital printing industry. Nur Ink Innovations is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Nur Ink Innovations stock
On Eulerpool you can find the complete historical development of EBITDA CAGR (5 Year) Nur Ink Innovations since 2006 – with annual values, charts, and detailed analysis.
The 5-year EBITDA CAGR shows the compound annual growth rate of EBITDA over five years.
To evaluate EBITDA CAGR (5 Year)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA CAGR (5 Year).
EBITDA CAGR (5 Year)'s is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA CAGR (5 Year)'s Nur Ink Innovations historically and in real time.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Growth — Nur Ink Innovations
Revenue GrowthRevenue CAGR 3YRevenue CAGR 5YRevenue CAGR 10YEarnings GrowthEPS GrowthEBIT GrowthEBIT CAGR 3YEBIT CAGR 5YEBIT CAGR 10YDividend GrowthFCF GrowthBook Value GrowthEarnings CAGR 3YEarnings CAGR 5YEarnings CAGR 10YEPS CAGR 3YEPS CAGR 5YEBITDA Growth YoYEBITDA CAGR 3YEBITDA CAGR 5YGross Profit GrowthOCF Growth YoYEmployee GrowthDividend CAGR 3YDividend CAGR 5YDividend CAGR 10YAsset GrowthEquity GrowthDebt GrowthCapEx GrowthFCF CAGR 3YFCF CAGR 5YMarket Cap GrowthShare Count Growth
All Key Metrics — Nur Ink Innovations
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth